Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

85826-32-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 85826-32-0 Structure
  • Basic information

    1. Product Name: 5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL
    2. Synonyms: 5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL;5-allyl-6-hydroxy-2-methylpyrimidin-4(3H)-one
    3. CAS NO:85826-32-0
    4. Molecular Formula: C8H10N2O2
    5. Molecular Weight: 166.18
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 85826-32-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 319°C at 760 mmHg
    3. Flash Point: 146.8°C
    4. Appearance: /
    5. Density: 1.245g/cm3
    6. Vapor Pressure: 0.000186mmHg at 25°C
    7. Refractive Index: 1.588
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL(85826-32-0)
    12. EPA Substance Registry System: 5-ALLYL-2-METHYL-4,6-PYRIMIDINEDIOL(85826-32-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 85826-32-0(Hazardous Substances Data)

85826-32-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 85826-32-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,8,2 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 85826-32:
(7*8)+(6*5)+(5*8)+(4*2)+(3*6)+(2*3)+(1*2)=160
160 % 10 = 0
So 85826-32-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O2/c1-3-4-6-7(11)9-5(2)10-8(6)12/h3H,1,4H2,2H3,(H2,9,10,11,12)

85826-32-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-hydroxy-2-methyl-5-prop-2-enyl-1H-pyrimidin-6-one

1.2 Other means of identification

Product number -
Other names 6-hydroxy-2-methyl-5-(2-propen-1-yl)-4(1H)-pyrimidinone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:85826-32-0 SDS

85826-32-0Relevant articles and documents

Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available g protein-coupled receptor 119 agonists

Katamreddy, Subba R.,Carpenter, Andrew J.,Ammala, Carina E.,Boros, Eric E.,Brashear, Ron L.,Briscoe, Celia P.,Bullard, Sarah R.,Caldwell, Richard D.,Conlee, Christopher R.,Croom, Dallas K.,Hart, Shane M.,Heyer, Dennis O.,Johnson, Paul R.,Kashatus, Jennifer A.,Minick, Doug J.,Peckham, Gregory E.,Ross, Sean A.,Roller, Shane G.,Samano, Vicente A.,Sauls, Howard R.,Tadepalli, Sarva M.,Thompson, James B.,Xu, Yun,Way, James M.

, p. 10972 - 10994 (2013/02/25)

GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines were discovered as G protein-coupled receptor 119

GPR119 AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS

-

Page/Page column 80, (2010/11/29)

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.

CONDENSED N-HETEROCYCLIC COMPOUNDS AND THEIR USE AS CRF RECEPTOR ANTAGONISTS

-

Page 22, (2010/02/09)

The present invention provides compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof (Formula (I)) wherein the dashed line may represent a double bond; R is aryl or heteroaryl, each of which m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 85826-32-0